StemCo Biomedical

company

About

StemCo Biomedical is a developer of medical device products for stem cell transplantation

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$9.80M
Industries
Biotechnology,Medical,Medical Device
Founded date
Jan 1, 1999
Number Of Employee
1 - 10
Operating Status
Active

StemCo Biomedical, Inc. was founded in 1999 and is located in the Research Triangle Park area of NC. The Company is engaged in the development, manufacture and distribution of a series of medical products designed to improve therapeutic transplantation of adult hematopoetic stem and progenitor cells derived from bone marrow, peripheral blood or umbilical cord blood. Addressing a market of more than $1 billion annually, the Company will have a series of products on the market starting in 2002 that identify, sort and custom-engineer stem cell grafts based upon cellular expression of ALDH resulting in what may be better, more effective stem cell transplants in the future.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$9.80M
StemCo Biomedical has raised a total of $9.80M in funding over 2 rounds. Their latest funding was raised on Mar 18, 2003 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 18, 2003 Series B $9.80M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
StemCo Biomedical is funded by 1 investors. The Trelys Funds are the most recent investors.
Investor Name Lead Investor Funding Round
The Trelys Funds Series B